Related by context. All words. (Click for frequent words.) 59 metastatic malignant 59 eribulin mesylate 59 abacavir Ziagen 59 antithymocyte globulin 59 adjuvant cisplatin 58 concurrent chemoradiation 58 bacillus Calmette Guerin 58 Dacogen decitabine 58 anagrelide 58 rituximab Rituxan 58 miglustat 57 gemtuzumab ozogamicin 57 follicular thyroid cancer 57 ZACTIMA 57 Phase Ib IIa clinical 57 Velcade bortezomib 57 Vascugel ® 56 epoetin alpha 56 multicenter randomized controlled 56 mesilate 56 MYLOTARG 56 antiangiogenic agent 56 biliary tract cancer 56 thalidomide Thalomid 56 colorectal cancer liver metastases 56 patientswith 56 bronchogenic carcinoma 56 autologous transplantation 56 neoadjuvant treatment 56 circadian cytokine modulator 56 intratympanic 56 myeloid metaplasia 56 NSABP B 56 symptomatic paroxysmal AF 56 hepatorenal syndrome 55 recurrent metastatic 55 daily subcutaneous injections 55 pediatric pontine glioma 55 bortezomib Velcade 55 Evaluable 55 null responder 55 temozolomide Temodar 55 recurrent glioblastoma multiforme 55 generation purine nucleoside 55 MDCT scans 55 operable breast cancer 55 doxorubicin docetaxel 55 intracavitary 55 chemoradiation therapy 55 transarterial 55 chemotherapeutic regimen 55 metastatic uveal melanoma 55 urothelial bladder cancer 55 histologically proven 55 fallopian tube carcinoma 55 interstitial brachytherapy 55 Cytoxan ® 55 Waldenstrom macroglobulinemia 55 autologous SCT 55 PREVENT IV 55 renal artery stenting 55 refractory ovarian cancer 55 verteporfin 55 Vidaza azacitidine 55 peritoneal cancer 55 Resolute stent 55 choroidal vasculopathy 54 transcranial Doppler ultrasound 54 insulin glulisine 54 BrachySil TM 54 Cimzia TM 54 Xelox 54 nonsmall cell lung cancer 54 Cloretazine 54 chemoradiotherapy 54 TheraGuide 54 undergoing liver transplantation 54 sorafenib Nexavar 54 cinacalcet 54 metastatic gastric 54 Interferon Alfa 54 metastatic adenocarcinoma 54 hepatic encephalopathy HE 54 malignant ascites 54 glycoprotein IIb IIIa inhibitor 54 neoadjuvant chemoradiotherapy 54 debulking surgery 54 dimeglumine 54 intravenous tissue plasminogen 54 eflornithine 54 colorectal liver metastases 54 Fully Covered Stent 54 adjuvant radiotherapy 54 gefitinib Iressa 54 urothelial cancer 54 Veno Occlusive Disease 54 Platinol ® cisplatin 54 infused intravenously 54 pancreatic ductal 54 genitourinary cancers 54 irinotecan chemotherapy 54 adenoma recurrence 54 Avastin adjuvant 54 MGd 54 BR.# 54 TransMID 54 tacrolimus ointment 54 Mitomycin C 54 Helicobacter pylori eradication 54 diagnosing coronary artery 53 nonmetastatic 53 neoadjuvant setting 53 Lucanix 53 dual endothelin receptor antagonist 53 DCVax Brain 53 clevidipine 53 HSCT 53 TASKi3 53 cutaneous melanoma 53 Pegylated Liposomal Doxorubicin 53 VNP#M 53 papillary renal cell carcinoma 53 AmpliChip 53 metastatic neuroendocrine tumors 53 colorectal adenoma 53 immunosuppression therapy 53 TPV r 53 Surgical resection 53 relapsed MM 53 platelet inhibitor 53 unresectable inoperable 53 ductal adenocarcinoma 53 caspofungin 53 CaPSURE 53 Myelodysplastic Syndrome MDS 53 liposome formulation 53 interferon lozenges 53 randomized multicenter Phase III 53 external beam radiotherapy 53 malignant lymphomas 53 Temodar temozolomide 53 pretransplant 53 CTEPH 53 FDG-PET/CT 53 Genomic Grade 53 histologically confirmed 53 Hodgkin lymphoma HL 53 BPH LUTS 53 Rituxan rituximab 53 fosbretabulin 53 divalproex sodium 53 liver resection 53 abdominal irradiation 53 CHOP chemotherapy 53 induced hepatotoxicity 53 ORENCIA ® 53 micafungin 53 interferon ribavirin 53 metastatic malignant melanoma 53 venous thromboembolic disease 53 IIa trials 53 lapatinib Tykerb 53 pain palliation 53 myeloablative 53 Bevacizumab Avastin 53 paclitaxel poliglumex 53 cisplatin chemotherapy 53 autologous transplants 53 ibandronate 53 CIMZIA TM certolizumab pegol 53 prospective nonrandomized 53 gastrointestinal stromal tumors GISTs 53 Pemetrexed 52 TKI therapy 52 LungSign TM 52 paclitaxel Taxol 52 Stent Graft 52 transplantation ASCT 52 polycythemia vera PV 52 gastrointestinal stromal tumors GIST 52 denileukin diftitox 52 parenteral antibiotics 52 inhaled AAT 52 Eli Lilly Gemzar 52 monophasic 52 Pyridorin 52 paclitaxel Taxol R 52 Diastolic Heart Failure 52 liver metastasis 52 trastuzumab DM1 T DM1 52 Platinol ® 52 radiotherapy RT 52 mycophenolate mofetil MMF 52 percutaneous injection 52 cardiac perfusion 52 bladder carcinoma 52 Doxil ® 52 pamidronate 52 PhG alpha 1 52 Remune 52 prostate carcinomas 52 FDG PET imaging 52 hibernating myocardium 52 Pegylated Interferon 52 sitaxsentan 52 Gemzar gemcitabine 52 lymphomas leukemias 52 multikinase inhibitor 52 reteplase 52 beta estradiol 52 reslizumab 52 sacral nerve stimulation 52 Temsirolimus 52 Hydroxyurea 52 subcutaneously injected 52 pT2 52 MMP inhibitor 52 monoclonal anti 52 Arranon 52 Phase 1a clinical 52 microsatellite instability 52 stereotactic radiotherapy 52 ToGA 52 antiangiogenic drugs 52 pentostatin 52 recurrent glioblastoma multiforme GBM 52 depsipeptide 52 BrachySil ™ 52 cerebral vasospasm 52 Noxafil 52 euthyroid 52 Acute Decompensated Heart Failure 52 prospective multicenter study 52 chronic hemodialysis 52 basiliximab 52 radioimmunotherapy RIT 52 DVT prophylaxis 52 thyroid carcinoma 52 Modrenal 52 metastatic bladder 52 Sorafenib Nexavar 52 surgically resectable 52 imatinib mesylate Gleevec 52 alefacept 52 sargramostim 52 urothelial carcinoma 52 oral antiplatelet therapy 52 Phase III randomized controlled 52 Percutaneous Tibial Nerve Stimulation 52 Taxus Liberté 52 tumor nodules 52 intravenous tPA 52 Acute Coronary Syndromes ACS 52 octreotide LAR 52 ASSERT trial 52 fallopian tube cancers 52 Interferon beta 51 Neupogen ® 51 zotarolimus 51 hemodialysis patients 51 Temodar ® 51 CRRT 51 demonstrated antitumor activity 51 FOLFIRI alone 51 Bruton tyrosine kinase Btk 51 vidofludimus 51 rFVIII 51 atrioventricular block 51 Sutent sunitinib 51 preoperative chemotherapy 51 Taxol paclitaxel 51 Arzerra ofatumumab 51 Teysuno 51 cranial irradiation 51 SIR Spheres 51 KRAS mutations occur 51 HIPEC 51 dacarbazine chemotherapy 51 fludarabine cyclophosphamide 51 relapsing multiple sclerosis 51 Quinamed 51 rt PA 51 temsirolimus Torisel ® 51 carotid artery stenting CAS 51 erlotinib Tarceva 51 CLIRS 51 cidofovir 51 lenalidomide Revlimid 51 Cellcept 51 randomized multicenter trial 51 adalimumab Humira 51 assessing T DM1 51 Chronic lymphocytic leukemia 51 phase IIIb 51 Lucrin 51 microwave hyperthermia 51 erythropoietic 51 myocardial revascularization 51 chronic thromboembolic pulmonary 51 eosinophilic asthma 51 temozolomide TMZ 51 administered intraperitoneally 51 topically administered 51 Virologic 51 TLK# 51 TNM staging 51 Solorel 51 liposomal amphotericin B 51 NYHA functional class 51 bevacizumab Avastin 51 Ontak 51 cetuximab Erbitux ® 51 docetaxel Taxotere 51 NSCL cancer 51 angiographically 51 membranous nephropathy 51 CsA 51 Angiotensin Converting Enzyme 51 Glivec imatinib 51 hematological relapse 51 gastric adenocarcinoma 51 icatibant 51 Phase IIb clinical trials 51 peritoneal dialysis PD 51 etanercept Enbrel 51 Adjunctive 51 OvaRex MAb 51 androgen ablation 51 RAS mutations 51 Tarceva TM 51 metastatic ovarian cancer 51 NovoTTF #A 51 buccal spray 51 thrombocytopenic 51 CHAMPION PCI 51 Legg Calvé Perthes disease 51 radical cystectomy 51 novel oral anticoagulant 51 Fluconazole 51 Allogeneic 51 acupoint stimulation 51 platelet aggregation inhibitor 51 immunomodulatory therapies 51 AMEVIVE 51 flow cytometric 51 undergoing peritoneal dialysis 51 Resten MP 51 prostate carcinoma 51 inhaled iloprost 51 peginterferon alpha 51 PI3 kinase inhibitor 51 Gliadel Wafer 51 squamous cell carcinoma SCC 51 estramustine 51 Cintredekin besudotox 51 biochemical relapse 51 mitomycin C 51 paricalcitol 51 prostate adenocarcinoma 51 PSA nadir 51 Removab 51 recurrent GBM 51 mutated K ras 51 BEACOPP 50 squamous cell lung cancer 50 histamine dihydrochloride 50 trabectedin 50 lymphocytic leukemia 50 Epirubicin 50 Tacrolimus 50 Ziprasidone 50 dual antiplatelet 50 satraplatin Phase 50 Coronary Artery Bypass Graft 50 receiving highly emetogenic 50 relapsed ALL 50 Retreatment 50 functional mitral regurgitation 50 Thrombin 50 metastatic basal cell 50 pill Exanta 50 mitoxantrone chemotherapy 50 Campath alemtuzumab 50 Elitek 50 smoldering myeloma 50 BCR ABL inhibitor 50 acute myeloid 50 Onconase 50 Randomized Evaluation 50 APPRAISE 50 elevated transaminases 50 TNM classification 50 bleomycin 50 Oxaliplatin 50 antiangiogenic therapy 50 aromatase inhibitor therapy 50 immunomodulatory therapy 50 parkinson disease 50 LHRH receptor positive 50 cediranib 50 TAXUS ARRIVE 50 FinESS 50 sunitinib Sutent 50 tumor histology 50 MAGE A3 ASCI 50 Zemplar Capsules 50 prucalopride 50 randomized Phase IIb 50 pharmacokinetic PK study 50 alpha1 antitrypsin deficiency 50 bronchoalveolar lavage 50 ZOLINZA 50 intralesional 50 Lilly Gemzar 50 allogeneic hematopoietic stem cell 50 T1a 50 Carotid endarterectomy 50 ara C 50 PROLARIS 50 defibrillator implant 50 stage IIIB 50 Cyclosporin 50 stem cell engraftment 50 CALGB # [002] 50 ixabepilone 50 Neo Bladder Augment 50 intradermal injections 50 pulmonary resection 50 radiotherapeutic 50 GnRH agonist 50 localized renal 50 multicentre prospective 50 leukemia AML 50 Zerenex TM 50 Sipuleucel T 50 Intravitreal 50 pediatric acute lymphoblastic 50 thetreatment 50 rtPA 50 paclitaxel carboplatin 50 Neulasta ® 50 Phase #b/#a clinical 50 haematological cancers 50 refractory colorectal cancer 50 Carotid Revascularization Endarterectomy vs. 50 multicenter Phase II 50 bile duct cancers 50 Squalamine 50 histological subtype 50 5 Fluorouracil 50 Glioblastoma Multiforme GBM 50 Fenretinide 50 HCPCS code 50 nCPAP 50 TURBT 50 FVIIa 50 multiple myeloma MM 50 Alequel ™ 50 erlotinib Tarceva ® 50 prostate cancer PCa 50 transurethral 50 subcutaneous methylnaltrexone 50 unresectable tumors 50 rFVIIa 50 TMJ dysfunction 50 Trovax 50 Irinotecan 50 Leucovorin 50 undergoing hematopoietic stem 50 intraperitoneal therapy 50 Zarnestra 50 pancreatic ductal adenocarcinoma 50 resected pancreatic cancer 50 allograft rejection 50 liposomal doxorubicin 50 visceral metastases 50 antiarrhythmic drug 50 Valdoxan 50 CA9 SCAN 50 malignant lymphoma 50 posttransplant 50 laparoscopic radical nephrectomy 50 EOquin TM 50 dasatinib Sprycel 50 Degarelix 50 MIRAPEX 50 haematopoietic stem cell 50 HDL Selective Delipidation 50 Roche Herceptin 50 VBLOC RF2 50 stem cell mobilizer 50 Tyrosine Kinase Inhibitors 50 genomic biomarker 50 LVRS 50 UPLYSO 50 peginterferon alpha 2a 50 NAVISTAR R 50 neo adjuvant 50 pT3 50 PEG IFN 49 busulfan 49 AGILECT R 49 receptor tyrosine kinase inhibitor 49 AOD# [002] 49 Acute Myeloid Leukaemia AML 49 ORAL HYCAMTIN 49 ultrasonographic examination 49 PEGPH# 49 ureteral stones 49 Viatronix V3D Colon 49 Bendamustine 49 metastatic RCC 49 hypertension PAH 49 tipranavir r 49 myeloproliferative disorder 49 pancreatic transplantation 49 Renal Cell Carcinoma RCC 49 lymphoid malignancies 49 F FDG PET 49 vasopressor 49 cutaneous squamous cell carcinoma 49 Onrigin 49 HCV Genotype 49 malignant pleural mesothelioma 49 epirubicin 49 anti angiogenic agents 49 postoperative infection 49 OnDose 49 hESC derived cardiomyocytes 49 Imatinib Mesylate 49 BETAS 49 LDR brachytherapy 49 pegfilgrastim 49 beta interferons 49 Resynchronization 49 CLL SLL 49 mg kg BID 49 demethylating agent 49 Neoadjuvant 49 recurrent prostate cancer 49 p# biomarker 49 proteasome inhibitor bortezomib 49 neoadjuvant chemotherapy 49 Cardiotoxicity 49 serum biomarker 49 Unstable Angina 49 GW# [003] 49 urography 49 ICD implants 49 hypomethylating agent 49 intestinal permeability 49 ImmuKnow R 49 5-fluorouracil/leucovorin 49 Cand5 49 non resectable 49 Intracoronary 49 Lung transplantation 49 idiopathic pulmonary arterial hypertension 49 cardiac repolarization 49 metastatic HER2 positive 49 T1c 49 coronary intervention 49 PACCE 49 ALA PDT 49 certolizumab 49 somatostatin analog 49 sunitinib malate 49 fluvastatin 49 olmesartan 49 radiation dosimetry 49 pegylated liposomal doxorubicin 49 trastuzumab Herceptin ® 49 PROCRIT R 49 Shc 49 Alequel 49 estrogen estradiol 49 polycythemia vera essential thrombocythemia 49 radiofrequency ablation RFA 49 briakinumab 49 Intergroup Exemestane Study 49 NOD SCID mice 49 HCl capsules 49 palifermin 49 ritonavir boosted 49 sipuleucel T 49 Gleevec imatinib mesylate 49 ribavirin Copegus ® 49 ACE Inhibitor 49 pancreatic adenocarcinoma 49 Echocardiographic 49 Idiopathic Pulmonary Fibrosis 49 PI3K/Akt pathway inhibitor 49 immunopathology 49 interferon beta 1b 49 OZURDEX 49 paroxysmal atrial fibrillation 49 desvenlafaxine succinate 49 molecular remissions 49 omacetaxine mepesuccinate 49 V3D Colon 49 dose melphalan 49 inoperable pancreatic cancer 49 antibody MAb 49 renoprotective 49 FOLFOX6 49 etoposide 49 aripiprazole Abilify 49 Deforolimus 49 esophageal gastric 49 Phase Ib clinical 49 primary hyperparathyroidism 49 p# MAP kinase inhibitor 49 Femara letrozole 49 atherosclerotic renal artery stenosis 49 RE LY trial 49 prospective multicenter randomized 49 cilengitide 49 Myocardial Perfusion Imaging 49 GAMMAGARD 49 Sirolimus eluting 49 PFO migraine 49 acute lymphoblastic 49 HLA A2 49 symptomatic intracranial 49 levodopa induced 49 relapsed ovarian cancer 49 androgen suppression 49 viral kinetics 49 Toraymyxin 49 antithrombotic therapy 49 Sprycel dasatinib 49 DCVax 49 biologic DMARD 49 graft occlusion 49 inhibitor RG# 49 mg clopidogrel 49 gastrointestinal stromal tumor GIST 49 keratoplasty 49 imexon 49 medically refractory 49 Adult Stem Cell Therapy 49 OVATURE 49 Kinoid 49 Allovectin 7 49 Zilver PTX stent 49 huN# DM1 49 brivanib 49 Myelodysplastic Syndrome 49 induce remission 49 Cetuximab Erbitux 49 prostate cancer mCRPC 49 neo adjuvant chemotherapy 49 gadobutrol 49 galiximab 49 Phase III VISTA 49 confirmatory clinical 49 Trabectedin 49 ancrod 49 advanced medullary thyroid 49 thymectomy 48 neurologic progression 48 colony stimulating factors 48 pancreatic carcinoma 48 VTE prophylaxis 48 uterine fibroid 48 intravesical chemotherapy 48 DCVax ® Brain 48 eluting stent 48 Subgroup analysis 48 sirolimus eluting stents 48 undergoing radical cystectomy 48 sacrocolpopexy 48 MIST II 48 RE MODEL 48 leukoencephalopathy 48 Gefitinib 48 multicenter randomized placebo controlled 48 recurrent glioblastoma 48 IVTA 48 XYOTAX TM 48 #mg/m# [002] 48 gemcitabine carboplatin 48 donepezil Aricept 48 mycophenolate mofetil 48 subconjunctival injection 48 hydroxamic acid 48 radioiodine therapy 48 thorough QT 48 methotrexate therapy 48 REPLACE Registry 48 ULORIC 48 Teriflunomide 48 COPERNICUS 48 mechanical thrombectomy 48 phase IIb III 48 NMIBC 48 imatinib therapy 48 undetectable HBV DNA 48 Aflibercept 48 thromboembolic disease 48 Talotrexin 48 Bosentan 48 node dissection 48 Alternans 48 Evoltra 48 OHR/AVR# 48 patients undergoing CABG 48 Gemcitabine 48 glucocorticoid therapy 48 myocardial necrosis 48 leflunomide 48 EBUS FNA 48 Antigen CEA 48 oral clodronate 48 Cyclophosphamide 48 RE LY ® 48 Medicsight ColonCAD 48 Arimidex anastrozole 48 systemic JIA 48 Pertuzumab 48 2DG 48 underwent percutaneous coronary 48 VerifyNow 48 monoclonal antibody conjugated 48 Boehringer Ingleheim 48 HER2 amplification 48 HERCEPTIN 48 RHEO 48 interferon alfa 2a 48 intravenous thrombolysis 48 metastatic lung cancer 48 carotid stents 48 Panzem R NCD 48 Intra arterial 48 Risk Stratification 48 IDO inhibitor 48 Erlotinib 48 Adjuvant chemotherapy 48 mutated KRAS 48 antithrombotic agents 48 BCG refractory 48 laparoscopic partial nephrectomy 48 oral treprostinil 48 Familial Adenomatous Polyposis 48 FOLFOX4 48 Embolic Protection System 48 efficacy evaluable 48 Lenalidomide 48 Gleevec resistant 48 LV dysfunction 48 hMG 48 Biphasic 48 cervical lymph node 48 ribavirin RBV 48 Exemestane 48 ximelagatran 48 gemcitabine cisplatin 48 refractory Hodgkin 48 tumors GIST 48 histone deacetylase inhibitor 48 FDG PET CT 48 Endarterectomy 48 incisional hernias 48 lipodystrophy syndrome 48 Novartis Afinitor 48 basal cell carcinoma BCC 48 EBRT 48 gemcitabine Gemzar 48 HBV vaccine 48 prospective multicentre 48 beta blocker therapy 48 Central Venous Catheter 48 intravenous immunoglobulin IVIg 48 multidose 48 oral anticoagulation 48 CANCIDAS 48 humanised monoclonal antibody 48 Catena ® 48 hyperoxaluria 48 ACTOS ® 48 mild hepatic impairment 48 PEG Interferon 48 IRESSA 48 EURIDIS 48 endometrial hyperplasia 48 HALO# [002] 48 occlusive vascular 48 neoplastic lesions 48 rhBMP 2 48 anti arrhythmic drug 48 stem cell transplantations 48 recurrent bladder 48 ALK inhibitors 48 surgical revascularization 48 Decitabine 48 CellSearch ™ 48 Phase Ib II 48 induced neuropathy 48 refractory chronic lymphocytic 48 deferoxamine 48 refractory prostate cancer 48 bronchoalveolar lavage fluid 48 protease inhibitor PI 48 urine dipstick 48 prognostic biomarker 48 diagnose Alzheimer disease 48 prospectively randomized 48 BRIM2 48 Tykerb lapatinib 48 Tygacil 48 HIV HCV coinfected 48 mitomycin 48 Phenylketonuria PKU 48 HLA DR4 48 Implantable Cardioverter Defibrillator ICD 48 CARE HF 48 diagnosed glioblastoma 48 NuroPro PD 48 immunosuppressant drug 48 Hormonal therapy 48 mTOR inhibitor 48 metastatic renal cell carcinoma 48 ovarian malignancy 48 nonalcoholic steatohepatitis NASH 48 Virtual Histology 48 antimetabolite 48 corticosteroid dexamethasone 48 glatiramer acetate 48 chemotherapy docetaxel 48 radiation sensitizer 48 Photodynamic 48 sternal wound infections 48 antiplatelet agent 48 inhaled corticosteroid therapy 48 Anavex #-# 48 cardiac revascularization 48 LNG IUS 48 5FU 48 samalizumab 48 Crohn colitis 48 cisplatin resistant 48 Interferon alfa 48 renal transplants 48 curative therapy 48 Cystoscopy 48 percutaneous catheter 48 flavopiridol 48 prasugrel Effient 48 delipidation 48 Intravascular 48 PET CT scanning 48 pegylated interferon alfa 48 radical retropubic prostatectomy 48 Mantle Cell Lymphoma 48 murine models 48 Vascular Wrap 48 HepaSphere 48 phase IIa 48 Glioblastoma Multiforme 48 irreversible inhibitor 48 Ranibizumab 48 Omacetaxine 48 imatinib Gleevec 48 ADVANCE PD 48 Zybrestat 48 MIBG 48 gemcitabine Gemzar ® 48 Aggrenox ® 48 spontaneously regress 48 Kaposi sarcoma KS 48 eszopiclone 48 TYKERB 48 inotropic therapy 48 peginterferon alfa 2a #KD 48 basal cell skin 48 achieved sustained virological 48 multicenter phase 48 variceal bleeding 48 RE COVER 48 Panzem NCD 48 myeloproliferative disease 48 targeted antifolate 48 intravesical therapy 48 inhaled treprostinil 48 Power Infuser 48 cytotoxic therapy 48 TACE 48 ependymoma 48 C#BL 6 mice 48 Cetuximab 48 Angiox R 48 Accelerated Partial Breast Irradiation 47 EP #R 47 risperidone Risperdal 47 dose cohort 47 SANVAR 47 Tumor Microenvironment 47 Phase III multicenter 47 Radiofrequency Ablation RFA 47 lenalidomide Revlimid R 47 ABVD 47 PRESEPT study 47 Nesiritide 47 azacytidine 47 BRCA mutation carriers 47 chemosensitivity 47 enlarged prostate glands 47 SR# [004] 47 aPTT 47 Flu Cy 47 zalutumumab 47 irinotecan oxaliplatin 47 Prostate Px + 47 Fludarabine 47 intratumoral injection 47 receptor blocker 47 decitabine 47 TUMT 47 diagnostic biomarker 47 photocoagulation 47 fistulizing Crohn disease 47 adjuvant colon cancer 47 endoluminal 47 tinzaparin 47 atypical hemolytic uremic syndrome 47 Vernakalant 47 colon carcinoma 47 dermal collagen 47 mRCC 47 cardioverter defibrillator 47 mTOR inhibitors 47 adjuvant trastuzumab 47 OncoVex 47 transarterial chemoembolization 47 administered subcutaneously 47 Proellex TM 47 ß blockers 47 Catheter ablation 47 cardiac amyloidosis 47 pancreatic lung 47 ticagrelor Brilinta 47 HuMax EGFr 47 Enzyme Replacement Therapy 47 paclitaxel eluting stents 47 pelvic irradiation 47 Revlimid lenalidomide 47 Neuvenge 47 biologic DMARDs 47 pelvic lymphadenectomy 47 Adefovir 47 IABP 47 underwent resection 47 Serum creatinine 47 induced cytotoxicity 47 syngeneic 47 cholangiocarcinoma 47 Rilonacept 47 nodal metastasis 47 Roche Xeloda 47 cranial radiation 47 AneuRx 47 total abdominal hysterectomy 47 metastatic lymph nodes 47 Globulin 47 MELAS 47 haematologic malignancies 47 Arzerra TM 47 allogeneic hematopoietic cell 47 transdermal estradiol 47 Stereotactic Radiosurgery 47 ABSORB trial 47 Alvesco R 47 Peripheral Arterial 47 Heartmate II 47 boosted protease inhibitor 47 Hodgkin lymphoma NHL 47 oesophageal squamous cell carcinoma 47 Copegus ribavirin 47 Triapine 47 4mg/kg 47 PD LID 47 infusional 47 humanized monoclonal 47 Lymph node 47 multicenter clinical trials 47 Mycophenolate Mofetil 47 HER2 antibody 47 ChronVac C R 47 aliskiren amlodipine 47 exocrine pancreas 47 riociguat 47 neovascularisation 47 preclinical efficacy 47 adriamycin 47 prostate cancer CaP 47 Phase IIIB IV 47 adjuvant endocrine therapy 47 B Cell Lymphoma 47 Mammosite